About this trial
Thromboendarterectomy is the standard technique for the treatment of symptomatic occlusive lesions of the common femoral artery. It consists of surgically controlling the artery and interrupting circulation, opening the vessel and removing the atherosclerotic plaque. However, this technique is associated with healing difficulties, postoperative infections, and debilitating incisional pain. The rise of endovascular therapies, particularly at the coronary level, has led to the emergence of new deocclusion techniques, including rotational atherectomy. This technique relies on the use of an intravascular catheter that reams out the atherosclerotic plaque while re-aspirating the resulting debris. A few studies have examined the use of rotational atherectomy for occlusive lesions of the common femoral arteries, but have not evaluated its results compared to the standard treatment. The aim of this multicenter cohort is to describe the efficacy and safety of rotational atherectomy and the standard treatment, thromboendarterectomy, in symptomatic occlusive lesions affecting the common femoral artery.
Eligibility criteria
Qualifiers
Male or female patient over 18 years of age
Non-emergency
Claudicating patient with significant de novo calcified stenosis affecting the common femoral artery, technically eligible for revascularization by thromboendarterectomy or rotational atherectomy
Surgery planned with either technique
Disqualifiers
Patient contraindicated for either technique (for surgical or anesthesiological reasons)
Patient with asymptomatic lesions of the common femoral artery
Patient with a history of surgery or angioplasty/stenting of the femoral stump
Patient with occlusion of the ipsilateral common femoral artery or external iliac artery
Trial design
Treatments tested in this trial
- Atherectomy